308 related articles for article (PubMed ID: 27998283)
1. A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support.
Döring M; Borrego P; Büch J; Martins A; Friedrich G; Camacho RJ; Eberle J; Kaiser R; Lengauer T; Taveira N; Pfeifer N
Retrovirology; 2016 Dec; 13(1):85. PubMed ID: 27998283
[TBL] [Abstract][Full Text] [Related]
2. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.
Jensen MA; Li FS; van 't Wout AB; Nickle DC; Shriner D; He HX; McLaughlin S; Shankarappa R; Margolick JB; Mullins JI
J Virol; 2003 Dec; 77(24):13376-88. PubMed ID: 14645592
[TBL] [Abstract][Full Text] [Related]
3. Genotypic coreceptor analysis.
Sierra S; Kaiser R; Thielen A; Lengauer T
Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
[TBL] [Abstract][Full Text] [Related]
4. Hybrid approach for predicting coreceptor used by HIV-1 from its V3 loop amino acid sequence.
Kumar R; Raghava GP
PLoS One; 2013; 8(4):e61437. PubMed ID: 23596523
[TBL] [Abstract][Full Text] [Related]
5. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
Verrier F; Borman AM; Brand D; Girard M
AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
[TBL] [Abstract][Full Text] [Related]
6. Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage.
Svicher V; Alteri C; Artese A; Zhang JM; Costa G; Mercurio F; D'Arrigo R; Alcaro S; Palù G; Clementi M; Zazzi M; Andreoni M; Antinori A; Lazzarin A; Ceccherini-Silberstein F; Perno CF;
Antivir Ther; 2011; 16(7):1035-45. PubMed ID: 22024519
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?
Jiao Y; Wang P; Zhang H; Zhang T; Zhang Y; Zhu H; Wu H
Immunol Invest; 2011; 40(6):597-613. PubMed ID: 21513481
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
Garrido C; Roulet V; Chueca N; Poveda E; Aguilera A; Skrabal K; Zahonero N; Carlos S; García F; Faudon JL; Soriano V; de Mendoza C
J Clin Microbiol; 2008 Mar; 46(3):887-91. PubMed ID: 18199789
[TBL] [Abstract][Full Text] [Related]
9. CD4-dependent characteristics of coreceptor use and HIV type 1 V3 sequence in a large population of therapy-naive individuals.
Low AJ; Marchant D; Brumme CJ; Brumme ZL; Dong W; Sing T; Hogg RS; Montaner JS; Gill V; Cheung PK; Harrigan PR
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):219-28. PubMed ID: 18240966
[TBL] [Abstract][Full Text] [Related]
10. Prediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approach.
Sierra S; Kaiser R; Lübke N; Thielen A; Schuelter E; Heger E; Däumer M; Reuter S; Esser S; Fätkenheuer G; Pfister H; Oette M; Lengauer T
J Vis Exp; 2011 Dec; (58):. PubMed ID: 22157596
[TBL] [Abstract][Full Text] [Related]
11. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807
[TBL] [Abstract][Full Text] [Related]
12. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.
Raymond S; Delobel P; Mavigner M; Cazabat M; Souyris C; Sandres-Sauné K; Cuzin L; Marchou B; Massip P; Izopet J
AIDS; 2008 Sep; 22(14):F11-6. PubMed ID: 18753930
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor.
Jiang X; Feyertag F; Meehan CJ; McCormack GP; Travers SA; Craig C; Westby M; Lewis M; Robertson DL
J Virol; 2015 Nov; 89(22):11457-72. PubMed ID: 26339063
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].
Mulinge M; Lemaire M; Servais JY; Rybicki A; Struck D; da Silva ES; Verhofstede C; Lie Y; Seguin-Devaux C; Schmit JC; Bercoff DP
PLoS One; 2013; 8(5):e60566. PubMed ID: 23667426
[TBL] [Abstract][Full Text] [Related]
15. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
Foda M; Harada S; Maeda Y
Microbiol Immunol; 2001; 45(7):521-30. PubMed ID: 11529558
[TBL] [Abstract][Full Text] [Related]
16. Genotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failure.
Swenson LC; Chui CK; Brumme CJ; Chan D; Woods CK; Mo T; Dong W; Chapman D; Lewis M; Demarest JF; James I; Portsmouth S; Goodrich J; Heera J; Valdez H; Harrigan PR
Antimicrob Agents Chemother; 2013 Dec; 57(12):6122-30. PubMed ID: 24080655
[TBL] [Abstract][Full Text] [Related]
17. Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies.
Delobel P; Nugeyre MT; Cazabat M; Pasquier C; Marchou B; Massip P; Barre-Sinoussi F; Israël N; Izopet J
J Clin Microbiol; 2007 May; 45(5):1572-80. PubMed ID: 17329448
[TBL] [Abstract][Full Text] [Related]
18. Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage.
Sander O; Sing T; Sommer I; Low AJ; Cheung PK; Harrigan PR; Lengauer T; Domingues FS
PLoS Comput Biol; 2007 Mar; 3(3):e58. PubMed ID: 17397254
[TBL] [Abstract][Full Text] [Related]
19. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
[TBL] [Abstract][Full Text] [Related]
20. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]